Journal of Gynecology and Neonatal BiologyJournal of Gynecology and Neonatal BiologyJournal of Gynecology and Neonatal BiologyJournal of Gynecology and Neonatal Biology2380-5595Ommega Online PublishersNew Jersey, USA115710.15436/2380-5595.16.1158Research ArticleCervical Neoplasia in Women Living With HIV at Cervical Cancer Screening Clinics in Mutare, Eastern ZimbabweCervical Neoplasia in Women Living With HIV at Cervical Cancer Screening Clinics in Mutare, Eastern ZimbabweAuxilia ChidemeMunodawafa 1Faculty of Health Sciences Africa University Mutare Zimbabwe 2Provincial Medical Director at Ministry of Health and Child Care Editor* E-mail: amunodawafa1@gmail.com
The authors have declared that no competing interests exist.
20161511201622JGNB-16-RA-115806102016091120162016Creative Commons Attribution LicenseThis is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. nbsp Title Cervical neoplasia in women living with HIV at cervical cancer screening clinics in Mutare Zimbabwe 2015 Introduction Cervical cancer in H IV infected women occurs at a younger age and progresses faster compared to those without the HIV infection In resource limited setting with HIV prevalence like Zimbabwe targeted screening of women living with HIV is an option The aim of the study was to determine the prevalence of cervical neoplasia and the risk factors amongst HIV infected women attending cervical screening clinics Methods A cross sectional study was conducted at visual inspection with acetic acid and cervicography VIAC clinics in Mutare city in Eastern Zimbabwe from May to July 2015 Two hundred and forty four women living with HIV who were screened for cervical cancer were enrolled in the study Data were collected by an interviewer administered structured and pretested questionnaire Data was entered and analysed using Epi info version 7 0 Results Out of the 242 participants 77 31 8 had cervical abnormality For the abnormalities 28 underwent cryotherapy 29 for LEEP and 20 with invasive cancer were referred and attended to in gynaecological clinic History of genital warts AOR 5 80 2 00 16 90 having more than one lifetime sexual partner AOR 3 20 1 16 8 86 first pregnancy after the age of 18 AOR 0 32 0 10 0 97 CD4 count ge 250 copies mm3 at antiretroviral commencement AOR 0 27 0 09 0 85 and a latest CD4 count ge 500 cell mm3 AOR 0 25 0 09 0 68 were independent factors associated with cervical neoplasia Conclusion The prevalence of cervical neoplasia among women living with HIV is high and cervical screening should be part and parcel of management of these women The need of early initiation of highly active antiretrovirals cannot be over-emphasised 10